← Back to explorer

261G000469 - INFLIximab 100 MG INJ BIOSSIMILAR (ZESSLY)

TED · 306231-2026can-standardawardedNo deadline given

Buyer

NameUnidade Local de Saúde Santa Maria, E.P.E.

CountryPT

Published2026-05-05

Deadline—

Value

Estimated€727,088 · 727,088 EUR

Awarded€727,088 · 727,088 EUR

WinnerSANDOZ FARMACEUTICA, LDA

See this firm's wins →

CPV codes

33652000 Medical equipment & pharmaceuticals

Description

INFLIximab 100 MG INJ BIOSSIMILAR (ZESSLY)

Similar tenders

Closest by meaning — across languages, via embeddings.

PublishedTitleBuyerMatch
2026-05-05261G000431 - USTECINUMAB SOL INJ BIOSSIMILAR (PYZCHIVA)Unidade Local de Saúde Santa Maria, E.P.E. PT94%
2026-05-05261G000505 - AVALGLUCOSIDASE ALFA INJ 100MGUnidade Local de Saúde Santa Maria, E.P.E. PT94%
2026-05-05261G000262 - IMIglucerase INJ 400 UIUnidade Local de Saúde Santa Maria, E.P.E. PT94%
2026-05-05261G000381 - IMIglucerase INJ 400 UIUnidade Local de Saúde Santa Maria, E.P.E. PT94%
2026-05-05261G000314 - VELAglucerase alfa 400 U INJUnidade Local de Saúde Santa Maria, E.P.E. PT93%
2026-05-05261G000236 - NATALIzumab INJ 20MG/ML AMP 15 MLUnidade Local de Saúde Santa Maria, E.P.E. PT93%

Source

View the official notice on TED ↗